JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v3i3.756ArticleAnalysis of factors influencing the complications of Solitaire AB stent mechanical thrombectomy in patients with acute intracranial artery occlusionhttps://artdesignp.com/journal/JCNR/3/3/10.26689/jcnr.v3i3.756ZongXin,LiJingmei,LiuShugai,LiangQiuxia,LuoXiaojun,YanBo,GuoPeng,YangDongrong2019332019-07-10[Abstract] Objective: To investigate the influence factors of hemorrhage and stroke with retriever with Solitaire AB stent in patients with acute intracranial artery occlusion. Methods: A retrospective of 43 cases of patients with acute intracranial artery occlusion for endovascular treatment with Solitaire AB stent enrolled from March 2016 to June 2018 in our hospital, combining the characteristics of the patients of our city, through the clinical baseline data statistical analysis, complications screening of risk factors of complications. Results: There were 81.4% of patients who were dredged totally. The incidences of cerebral hemorrhage and infarction were 18.6% and 16.3%, cerebral hemorrhage group compared with control group, diabetes, blood pressure, revascularized time, NIHSS score, ASPECTS score had statistically significant differences, when infarction group compared with control group, age, opening time, ASITN_SIR score and grade of mTICI had statistically significant differences. Conclusion: Mechanical thrombectomy with Solitaire AB stent in patients with acute intracranial artery occlusion, the occurred of complications associated with various clinical factors, and the occurrence of complications seriously affect the prognosis of patients, therefore, selecting the indications strictly, and adopt individualized treatment to reduce complications.

Chen Zhu. Review sample survey report of the third national death cause [M]. Beijing: China Union Medical University Press, 2008: 10 – 17.

Lees K R, Bluhmki E, von Kummer R , et al, Time to treatment with intravenous alteplase and outcome stroke: an updated pooled analysis of ECASS, ATLANTIS,NINDS, and EPITHET trials[J]. Lancet, 2010，375(9727):1695-1703.

NOGUEIRA R G, JADHAV A P, HAUSSEN DC, et al. Thrombectomy 6 to 24 Hours after Stroke witha Mismatch between Deficit and Infarct[J]. N Engl J Med, 2018, 378(1): 1l-21.

ALBERS G W, MARKS MP, KEMPS, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging[J] . N EngI J Med,2018, 378 (8) : 708-718.

Bang O Y, Saver J L, Kim S J, et al. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke[J]. Stroke, 2011, 42(8): 2235-2239.

Li Liheng, Jiang Guihua, Xiao Chengjiang, et al. Comparative analysis of mechanical thrombectomy and stent thrombectomy combined with intro-arterial thrombolysis for acute cerebral artery occlusion [J]. Journal of Sun Yat-sen University (Medical Science Edition), 2014, 3, (3): 445 – 451.

Bang OY，Saver JL，Kim SJ，et al． Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke［J］． Stroke，2011，42(8) : 2235-2239．

WANG J. FU X, ZHANG D, et al. Effect of crenolanib. A nonselective inhibitor of PDGFR, In a mouse model of transient middle cerebral artery occlusion [J]. Neuros cience.2017.364: 202-211

Vagal A，Menon BK，Foster LD，et al． Association between CT angiogram collaterals and CT perfusion in the interventional management of stroke Ⅲ trial［J］．Stroke，2016，47 ( 2 ) :535-538．

CSOBAY-NOVÁK C，BÁRÁNY T，ZIMA E，et al. Role of stent selection in the incidence of persisting hemodynamic depression after carotid artery stenting[J]. J Endovasc Ther，2015，22（1）：122-129.

Yang Dong, Liu Xinfeng, Hao Yonggang, et al. The effect of retrievable stent size on the treatment of acute anterior circulation vascular occlusion treatment [J]. Chinese Journal of Stroke, 2018, 4, (13): 305 – 362.

Saver J L, Jahan R , Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke(SWIFT) : a randomised. Parallel-group. Non-inferiority trial[J]. Lancet 2012，380 (9849)：1241-1249.